Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Astral Codex Ten Podcast

Did a Melatonin Patent Inspire Current Dose Confusion?

14 Jul 2018

Description

Yesterday I wrote about melatonin, mentioning that most drugstore melatonin supplements were 10x or more the recommended dose. A commenter on Facebook pointed me to an interesting explanation of why. Dr. Richard Wurtman, an MIT scientist who helped discover melatonin's role in the body and pioneer its use as a sleep aid, writes: MIT was so excited about our research team's melatonin-sleep connection discovery that they decided to patent the use of reasonable doses of melatonin—up to 1 mg—for promoting sleep. But they made a big mistake. They assumed that the FDA would want to regulate the hormone and its use as a sleep therapy. They also thought the FDA wouldn't allow companies to sell melatonin in doses 3-times, 10-times, even 15-times more than what's necessary to promote sound sleep. Much to MIT's surprise, however, the FDA took a pass on melatonin. At that time, the FDA was focusing on other issues, like nicotine addiction, and they may have felt they had bigger fish to fry. Also, the FDA knew that the research on melatonin showed it to be non-toxic, even at extremely high doses, so they probably weren't too worried about how consumers might use it. In the end, and as a way of getting melatonin on to the market, the FDA chose to label it a dietary supplement, which does not require FDA regulation. Clearly, this was wrong because melatonin is a hormone, not a dietary supplement. Quickly, supplement manufacturers saw the huge potential in selling melatonin to promote good sleep. After all, millions of Americans struggled to get to sleep and stay asleep, and were desperate for safe alternatives to anti-anxiety medicines and sleeping pills that rarely worked well and came with plenty of side effects. Also, manufacturers must have realized that they could avoid paying royalties to MIT for melatonin doses over the 1 mg measure. So, they produced doses of 3 mg, 5 mg, 10 mg and more! Their thinking–like so much else in our American society–was likely, "bigger is better!" But, they couldn't be more wrong. So he's saying that…in order to get around a patent on using the correct dose of melatonin…supplement manufacturers…used the wrong dose of melatonin? I enjoy collecting stories of all the crazy perversities created by our current pharmaceutical system, but this one really takes the cake.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.